Global AI in Clinical Trials Market Research Report – Segmented By Clinical Trial Phase (Phase-I, Phase-II, Phase-III); By Application (Oncology, Cardiovascular Diseases, Neurological Diseases or Conditions, Metabolic Diseases, Infectious Diseases, Others); By End User (Pharmaceutical Companies, Academia, Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - Jan
Report Code: IM-3251
Format:
Region: Global
Ask an Expert
Choose License Type
$
2850
$
5250
$
4500
$
1800
